JP2015145410A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015145410A5 JP2015145410A5 JP2015079415A JP2015079415A JP2015145410A5 JP 2015145410 A5 JP2015145410 A5 JP 2015145410A5 JP 2015079415 A JP2015079415 A JP 2015079415A JP 2015079415 A JP2015079415 A JP 2015079415A JP 2015145410 A5 JP2015145410 A5 JP 2015145410A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- tablet
- composition
- substituted
- disintegrant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US73763105P | 2005-11-17 | 2005-11-17 | |
| US60/737,631 | 2005-11-17 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012135063A Division JP6049317B2 (ja) | 2005-11-17 | 2012-06-14 | 医薬組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015145410A JP2015145410A (ja) | 2015-08-13 |
| JP2015145410A5 true JP2015145410A5 (https=) | 2015-09-24 |
| JP6147290B2 JP6147290B2 (ja) | 2017-06-14 |
Family
ID=37875983
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008541365A Withdrawn JP2009515993A (ja) | 2005-11-17 | 2006-11-16 | 医薬組成物 |
| JP2012135063A Expired - Fee Related JP6049317B2 (ja) | 2005-11-17 | 2012-06-14 | 医薬組成物 |
| JP2015079415A Expired - Fee Related JP6147290B2 (ja) | 2005-11-17 | 2015-04-08 | 医薬組成物 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008541365A Withdrawn JP2009515993A (ja) | 2005-11-17 | 2006-11-16 | 医薬組成物 |
| JP2012135063A Expired - Fee Related JP6049317B2 (ja) | 2005-11-17 | 2012-06-14 | 医薬組成物 |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US20080255048A1 (https=) |
| EP (1) | EP1951207A2 (https=) |
| JP (3) | JP2009515993A (https=) |
| KR (2) | KR20140053419A (https=) |
| CN (1) | CN101309674A (https=) |
| AU (1) | AU2006318815B2 (https=) |
| BR (1) | BRPI0618723A2 (https=) |
| CA (1) | CA2626933C (https=) |
| RU (1) | RU2469709C2 (https=) |
| WO (1) | WO2007061829A2 (https=) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8497258B2 (en) | 2005-11-12 | 2013-07-30 | The Regents Of The University Of California | Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract |
| RU2469709C2 (ru) * | 2005-11-17 | 2012-12-20 | Новартис Аг | Фармацевтическая композиция |
| US20110097401A1 (en) | 2009-06-12 | 2011-04-28 | Meritage Pharma, Inc. | Methods for treating gastrointestinal disorders |
| MX377589B (es) | 2010-12-16 | 2025-03-10 | Novo Nordisk As | Composiciones sólidas que comprenden agonista de glp-1 y sal del ácido n-(8-(2-hidroxibenzoil)amino)caprílico. |
| RU2602601C2 (ru) | 2011-04-12 | 2016-11-20 | Ново Нордиск А/С | Дважды ацилированные производные glp-1 |
| EP3542790B1 (en) | 2012-03-22 | 2023-09-13 | Novo Nordisk A/S | Compositions comprising a delivery agent and preparation thereof |
| DK2827845T3 (en) | 2012-03-22 | 2019-04-01 | Novo Nordisk As | COMPOSITIONS INCLUDING A PROCEDURE AND PREPARING THEREOF |
| CN104203266B (zh) | 2012-03-22 | 2017-12-26 | 诺和诺德股份有限公司 | Glp‑1肽组合物及其制备 |
| JP6517690B2 (ja) | 2012-06-20 | 2019-05-22 | ノヴォ ノルディスク アー／エス | ペプチド及び送達剤を含む錠剤製剤 |
| JP6672140B2 (ja) | 2013-05-02 | 2020-03-25 | ノヴォ ノルディスク アー／エス | Ｇｌｐ−１化合物の経口投薬 |
| CN104095828A (zh) * | 2014-07-29 | 2014-10-15 | 中国药科大学 | 一种降钙素口服肠溶组合物及其制备方法 |
| CN113713090B (zh) * | 2015-02-09 | 2023-06-02 | 安特拉贝欧有限公司 | 骨质疏松症的治疗 |
| IL264880B2 (en) * | 2016-08-17 | 2024-09-01 | Entera Bio Ltd | Preparations for oral administration of active substances |
| PL3746111T3 (pl) | 2018-02-02 | 2024-01-15 | Novo Nordisk A/S | Stałe kompozycje zawierające agonistę glp-1 i sól kwasu n-(8-(2- hydroksybenzoilo)amino kaprylowego i substancję poślizgową |
| CN111116684B (zh) * | 2019-12-31 | 2020-09-25 | 厦门甘宝利生物医药有限公司 | 一种具有甲状腺激素受体激动剂特性的肝靶向化合物及其药物组合物 |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5866A (en) | 1848-10-17 | Dentist s deill | ||
| US608618A (en) | 1898-08-09 | Thomas millen | ||
| US5773A (en) | 1848-09-19 | Sizing and drying cotton-batting | ||
| US536A (en) | 1837-12-26 | Beady binder for binding newspapers | ||
| US647A (en) | 1838-03-21 | Improved fishing-seine for deep water | ||
| AU508480B2 (en) * | 1977-04-13 | 1980-03-20 | Asahi Kasei Kogyo Kabushiki Kaisha | Microcrystalline cellulose excipient and pharmaceutical composition containing thesame |
| DE3524572A1 (de) * | 1985-07-10 | 1987-01-15 | Thomae Gmbh Dr K | Feste arzneimittelformen zur peroralen anwendung enthaltend 9-deoxo-11-deoxy-9,11-(imino(2-(2-methoxyethoxy)ethyliden)-oxy)-(9s)-erythromycin und verfahren zu ihrer herstellung |
| US5096714A (en) * | 1988-06-28 | 1992-03-17 | Hauser-Kuhrts, Inc. | Prolonged release drug tablet formulations |
| JP2609022B2 (ja) * | 1990-11-29 | 1997-05-14 | 北陸製薬株式会社 | ポリカルボフィルカルシウム含有製剤 |
| US6191105B1 (en) | 1993-05-10 | 2001-02-20 | Protein Delivery, Inc. | Hydrophilic and lipophilic balanced microemulsion formulations of free-form and/or conjugation-stabilized therapeutic agents such as insulin |
| US5681811A (en) | 1993-05-10 | 1997-10-28 | Protein Delivery, Inc. | Conjugation-stabilized therapeutic agent compositions, delivery and diagnostic formulations comprising same, and method of making and using the same |
| US5359030A (en) | 1993-05-10 | 1994-10-25 | Protein Delivery, Inc. | Conjugation-stabilized polypeptide compositions, therapeutic delivery and diagnostic formulations comprising same, and method of making and using the same |
| MX9706062A (es) * | 1995-02-08 | 1997-10-31 | Yamanouchi Europ Bv | FORMAS DE DOSIFICACION ORAL CONTENIENDO UN ANTIBIOTICO DE beta -LACTAMA. |
| TW442301B (en) * | 1995-06-07 | 2001-06-23 | Sanofi Synthelabo | Pharmaceutical compositions containing irbesartan |
| US5912014A (en) | 1996-03-15 | 1999-06-15 | Unigene Laboratories, Inc. | Oral salmon calcitonin pharmaceutical products |
| US6361794B1 (en) * | 1996-06-12 | 2002-03-26 | Basf Corporation | Method of making ibuprofen and narcotic analgesic composition |
| EP1175390B1 (en) | 1999-04-05 | 2005-02-02 | Emisphere Technologies, Inc. | Disodium salts, monohydrates, and ethanol solvates |
| US6309633B1 (en) | 1999-06-19 | 2001-10-30 | Nobex Corporation | Amphiphilic drug-oligomer conjugates with hydroyzable lipophile components and methods for making and using the same |
| US6380405B1 (en) | 1999-09-13 | 2002-04-30 | Nobex Corporation | Taxane prodrugs |
| US6436990B1 (en) | 1999-10-27 | 2002-08-20 | Nobex Corporation | 6-methoxy-2-naphthylacetic acid prodrugs |
| AU2001285489A1 (en) | 2000-08-29 | 2002-03-13 | Nobex Corporation | 5-ASA derivatives having anti-inflammatory and antibiotic activity and methods of treating diseases therewith |
| US7049283B2 (en) * | 2000-12-06 | 2006-05-23 | Novartis Ag | Pharmaceutical compositions for the oral delivery of pharmacologically active agents |
| US6479692B1 (en) | 2001-05-02 | 2002-11-12 | Nobex Corporation | Methods of synthesizing acylanilides including bicalutamide and derivatives thereof |
| PL211976B1 (pl) * | 2001-06-01 | 2012-07-31 | Novartis Ag | Kompozycja farmaceutyczna do podawania doustnego oraz zastosowanie kompozycji |
| US20050054557A1 (en) * | 2002-05-09 | 2005-03-10 | Goldberg Michael M. | Compositions for delivering parathyroid hormone and calcitonin |
| EP1545477A4 (en) * | 2002-09-13 | 2006-11-22 | Cydex Inc | CAPSULES CONTAINING AQUEOUS FILLING COMPOSITIONS STABILIZED WITH DERIVED CYCLODEXTRIN |
| US20070155664A1 (en) * | 2003-07-04 | 2007-07-05 | Nycomed Danmark A/S | Parathyroid hormone (pth) containing pharmaceutical compositions for oral use |
| MXPA06000807A (es) * | 2003-07-23 | 2006-08-23 | Novartis Ag | Uso de calcitonina en osteoartritis. |
| GB0422644D0 (en) * | 2004-10-12 | 2004-11-10 | Novartis Ag | Organic compounds |
| RU2469709C2 (ru) * | 2005-11-17 | 2012-12-20 | Новартис Аг | Фармацевтическая композиция |
-
2006
- 2006-11-16 RU RU2008123380/15A patent/RU2469709C2/ru not_active IP Right Cessation
- 2006-11-16 CN CNA2006800429006A patent/CN101309674A/zh active Pending
- 2006-11-16 KR KR1020147010618A patent/KR20140053419A/ko not_active Ceased
- 2006-11-16 US US12/093,383 patent/US20080255048A1/en not_active Abandoned
- 2006-11-16 AU AU2006318815A patent/AU2006318815B2/en not_active Ceased
- 2006-11-16 EP EP06837887A patent/EP1951207A2/en not_active Withdrawn
- 2006-11-16 BR BRPI0618723-4A patent/BRPI0618723A2/pt not_active IP Right Cessation
- 2006-11-16 CA CA2626933A patent/CA2626933C/en not_active Expired - Fee Related
- 2006-11-16 KR KR1020087011726A patent/KR101432313B1/ko not_active Expired - Fee Related
- 2006-11-16 JP JP2008541365A patent/JP2009515993A/ja not_active Withdrawn
- 2006-11-16 WO PCT/US2006/044642 patent/WO2007061829A2/en not_active Ceased
-
2011
- 2011-04-04 US US13/079,400 patent/US20110218148A1/en not_active Abandoned
-
2012
- 2012-06-14 JP JP2012135063A patent/JP6049317B2/ja not_active Expired - Fee Related
-
2015
- 2015-04-08 JP JP2015079415A patent/JP6147290B2/ja not_active Expired - Fee Related
- 2015-05-21 US US14/718,595 patent/US9622975B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015145410A5 (https=) | ||
| JP2021191784A5 (https=) | ||
| JP2019048894A5 (https=) | ||
| EP4483882A3 (en) | New methylquinazolinone derivatives | |
| JP2015024998A5 (https=) | ||
| JP2012509348A5 (https=) | ||
| JP2016534063A5 (https=) | ||
| UA104136C2 (ru) | Фармацевтическая композиция, которая включает ингибитор дпп-4 в комбинации с дополнительным противодиабетическим агентом, и способ ее получения | |
| JP2020097577A5 (https=) | ||
| JP2018518537A5 (https=) | ||
| BRPI0511327B8 (pt) | combinações de glicopirrolato e agonistas do adrenorreceptor beta2 | |
| RU2013119966A (ru) | Композиция, улучшающая растворимость плохорастворимого лекарственного препарата | |
| JP2010527365A5 (https=) | ||
| JP2019519533A5 (https=) | ||
| EA201290659A1 (ru) | Новая композиция ретигабина | |
| JP2010521516A5 (https=) | ||
| CY1120852T1 (el) | Φαρμακευτικη συνθεση η οποια περιλαμβανει ιβουπροφαινη, τραμαδολη και ενα βασικο αμινοξυ, μεθοδος παρασκευης αυτης και χρηση της ιδιας | |
| JOP20170197B1 (ar) | الصيغة الجديدة التي تشتمل على مشتق بنزيميدازول | |
| JP2008519768A5 (https=) | ||
| JP2008513510A5 (https=) | ||
| JP2017505809A5 (https=) | ||
| JP2019151627A5 (https=) | ||
| JP2016532632A5 (https=) | ||
| ZA202205756B (en) | Oral formulation of x842 | |
| JP2009503045A5 (https=) |